YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access

NO_LONGER_AVAILABLE

Conditions studied: Soft Tissue Sarcoma

In brief

The YONDELIS (trabectedin) Single Patient Compassionate Use /Expanded Access program provides patients with advanced soft tissue sarcoma, who do not qualify for ongoing clinical trials with YONDELIS (trabectedin), access to this investigational treatment.

Key facts

Study ID
NCT01427582
Run by
University of Texas Southwestern Medical Center
Last updated by the study team
2011-09-01

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.